Patent Assignment
Reel/Frame 045131/0353
Assignment of Assignor's Interest
Recorded: 2018-03-07
Pages: 6
Assignors
FERENCIC, MATHIAS
Executed: 2018-01-18
HEILMAYER, WERNER
Executed: 2018-01-16
HINSMANN, PETER
Executed: 2018-01-16
WICHA, WOLFGANG
Executed: 2018-01-16
Assignee
NABRIVA THERAPEUTICS GMBH
LEBERSTRASSE 20, A-1110 WIEN, AUSTRIA
Covered Property
(1)
Injectable Pharmaceutical Formulations of Lefamulin
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest
Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Assignment of Assignor's Interest
Jan 9, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 069806/0458 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →